OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary
Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, et al.
Endocrine Practice (2020) Vol. 26, Iss. 10, pp. 1196-1224
Closed Access | Times Cited: 203
Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, et al.
Endocrine Practice (2020) Vol. 26, Iss. 10, pp. 1196-1224
Closed Access | Times Cited: 203
Showing 1-25 of 203 citing articles:
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, et al.
Endocrine Practice (2022) Vol. 28, Iss. 10, pp. 923-1049
Open Access | Times Cited: 327
Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, et al.
Endocrine Practice (2022) Vol. 28, Iss. 10, pp. 923-1049
Open Access | Times Cited: 327
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
Susan L. Samson, Priyathama Vellanki, Lawrence Blonde, et al.
Endocrine Practice (2023) Vol. 29, Iss. 5, pp. 305-340
Open Access | Times Cited: 213
Susan L. Samson, Priyathama Vellanki, Lawrence Blonde, et al.
Endocrine Practice (2023) Vol. 29, Iss. 5, pp. 305-340
Open Access | Times Cited: 213
Ten things to know about ten cardiovascular disease risk factors
Harold Bays, Pam R. Taub, Elizabeth Epstein, et al.
American Journal of Preventive Cardiology (2021) Vol. 5, pp. 100149-100149
Open Access | Times Cited: 176
Harold Bays, Pam R. Taub, Elizabeth Epstein, et al.
American Journal of Preventive Cardiology (2021) Vol. 5, pp. 100149-100149
Open Access | Times Cited: 176
Ten things to know about ten cardiovascular disease risk factors – 2022
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 82
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 82
Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States
Harpreet Bhatia, Samantha Hurst, Paresh Desai, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 18
Open Access | Times Cited: 47
Harpreet Bhatia, Samantha Hurst, Paresh Desai, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 18
Open Access | Times Cited: 47
Lipoprotein(a) and cardiovascular disease
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 27
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 27
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 23
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 19
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 19
American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
Shailendra B. Patel, Kathleen Wyne, Samina Afreen, et al.
Endocrine Practice (2025) Vol. 31, Iss. 2, pp. 236-262
Closed Access | Times Cited: 5
Shailendra B. Patel, Kathleen Wyne, Samina Afreen, et al.
Endocrine Practice (2025) Vol. 31, Iss. 2, pp. 236-262
Closed Access | Times Cited: 5
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study
Shujie Wang, Huahui Ren, Huanzi Zhong, et al.
Gut Microbes (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Shujie Wang, Huahui Ren, Huanzi Zhong, et al.
Gut Microbes (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds
Sotirios Tsimikas, Santica M. Marcovina
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 9, pp. 934-946
Open Access | Times Cited: 63
Sotirios Tsimikas, Santica M. Marcovina
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 9, pp. 934-946
Open Access | Times Cited: 63
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
Lawrence A. Leiter, Maciej Banach, Alberico L. Catapano, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 868-880
Open Access | Times Cited: 53
Lawrence A. Leiter, Maciej Banach, Alberico L. Catapano, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 868-880
Open Access | Times Cited: 53
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)
Christie M. Ballantyne, Maciej Banach, Harold Bays, et al.
The American Journal of Cardiology (2022) Vol. 174, pp. 1-11
Open Access | Times Cited: 46
Christie M. Ballantyne, Maciej Banach, Harold Bays, et al.
The American Journal of Cardiology (2022) Vol. 174, pp. 1-11
Open Access | Times Cited: 46
American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity
Karl Nadolsky, Brandi Addison, Monica Agarwal, et al.
Endocrine Practice (2023) Vol. 29, Iss. 6, pp. 417-427
Open Access | Times Cited: 28
Karl Nadolsky, Brandi Addison, Monica Agarwal, et al.
Endocrine Practice (2023) Vol. 29, Iss. 6, pp. 417-427
Open Access | Times Cited: 28
Diabetes and Dyslipidemia
Kenneth R. Feingold, Carl Grünfeld
Contemporary cardiology (2023), pp. 425-472
Closed Access | Times Cited: 24
Kenneth R. Feingold, Carl Grünfeld
Contemporary cardiology (2023), pp. 425-472
Closed Access | Times Cited: 24
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Faizan Mazhar, Anne‐Laure Faucon, Edouard L. Fu, et al.
European Heart Journal (2024)
Open Access | Times Cited: 12
Faizan Mazhar, Anne‐Laure Faucon, Edouard L. Fu, et al.
European Heart Journal (2024)
Open Access | Times Cited: 12
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel Soffer, Nicholas Marston, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e647-e663
Closed Access | Times Cited: 10
Daniel Soffer, Nicholas Marston, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e647-e663
Closed Access | Times Cited: 10
SEA 2024 Standards for Global Control of Vascular Risk
José María Mostaza, Xavier Pintó, Pedro Armario, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2024) Vol. 36, Iss. 3, pp. 133-194
Open Access | Times Cited: 9
José María Mostaza, Xavier Pintó, Pedro Armario, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2024) Vol. 36, Iss. 3, pp. 133-194
Open Access | Times Cited: 9
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Journal of Diabetes and its Complications (2021) Vol. 36, Iss. 2, pp. 108101-108101
Open Access | Times Cited: 47
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Journal of Diabetes and its Complications (2021) Vol. 36, Iss. 2, pp. 108101-108101
Open Access | Times Cited: 47
Real‐world performance of the MiniMed™ 670G system in Europe
Julien Da Silva, Emanuele Bosi, Johan Jendle, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 8, pp. 1942-1949
Closed Access | Times Cited: 45
Julien Da Silva, Emanuele Bosi, Johan Jendle, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 8, pp. 1942-1949
Closed Access | Times Cited: 45
New Therapies for Primary Hyperlipidemia
Carlos A. Aguilar‐Salinas, Rita A. Gómez‐Díaz, Pablo Corral
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 5, pp. 1216-1224
Open Access | Times Cited: 45
Carlos A. Aguilar‐Salinas, Rita A. Gómez‐Díaz, Pablo Corral
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 5, pp. 1216-1224
Open Access | Times Cited: 45
LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals
James Underberg, Peter P. Tóth, Fátima Rodríguez
Postgraduate Medicine (2022) Vol. 134, Iss. 8, pp. 752-762
Open Access | Times Cited: 36
James Underberg, Peter P. Tóth, Fátima Rodríguez
Postgraduate Medicine (2022) Vol. 134, Iss. 8, pp. 752-762
Open Access | Times Cited: 36
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
Rita Basu, Mazen Noureddin, Jeanne M. Clark
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 9, pp. 1700-1716
Open Access | Times Cited: 34
Rita Basu, Mazen Noureddin, Jeanne M. Clark
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 9, pp. 1700-1716
Open Access | Times Cited: 34
Functional Roles of Furin in Cardio-Cerebrovascular Diseases
Surasak Wichaiyo, Pimpisid Koonyosying, Noppawan Phumala Morales
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 570-585
Open Access | Times Cited: 8
Surasak Wichaiyo, Pimpisid Koonyosying, Noppawan Phumala Morales
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 570-585
Open Access | Times Cited: 8
Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice
Diana De Oliveira-Gomes, Parag H. Joshi, Eric D. Peterson, et al.
Circulation (2024) Vol. 150, Iss. 1, pp. 62-79
Closed Access | Times Cited: 8
Diana De Oliveira-Gomes, Parag H. Joshi, Eric D. Peterson, et al.
Circulation (2024) Vol. 150, Iss. 1, pp. 62-79
Closed Access | Times Cited: 8
